{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:55:19Z","timestamp":1768686919034,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.exer.2020.108178","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T20:10:55Z","timestamp":1596485455000},"page":"108178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2270-9219","authenticated-orcid":false,"given":"Brian C.","family":"Tse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Dvoriantchikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-2324","authenticated-orcid":false,"given":"Ryan A.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5573-4402","authenticated-orcid":false,"given":"Dmitry","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pelaez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.108178_bib1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2012121216","article-title":"The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin","volume":"24","author":"Birk","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.exer.2020.108178_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1074248413508003","article-title":"Reduction of early reperfusion injury with the mitochondria-targeting peptide Bendavia","volume":"19","author":"Brown","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"issue":"8","key":"10.1016\/j.exer.2020.108178_bib3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3109\/02713683.2014.959607","article-title":"Mitochondria-targeted antioxidant peptide SS31 protects cultured human lens epithelial cells against oxidative stress","volume":"40","author":"Cai","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2020.108178_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jnnp.74.2.246","article-title":"Visual prognosis after indirect traumatic optic neuropathy","volume":"74","author":"Carta","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.exer.2020.108178_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/ICU.0000000000000198","article-title":"Is there treatment for traumatic optic neuropathy?","volume":"26","author":"Chaon","year":"2015","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"10","key":"10.1016\/j.exer.2020.108178_bib6","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1167\/iovs.11-7524","article-title":"Mitochondria-targeted peptide MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells","volume":"52","author":"Chen","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108178_bib7","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3892\/mmr.2017.6271","article-title":"Protective effect of mitochondria-targeted peptide MTP-131 against oxidative stress-induced apoptosis in RGC-5 cells","volume":"15","author":"Chen","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.exer.2020.108178_bib8","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.1523\/JNEUROSCI.19-19-08367.1999","article-title":"Optic nerve crush: axonal responses in wild-type and bcl-2 transgenic mice","volume":"19","author":"Chierzi","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2020.108178_bib9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCHEARTFAILURE.113.000406","article-title":"Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides","volume":"6","author":"Dai","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.exer.2020.108178_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1083\/jcb.200906098","article-title":"Coassembly of Mgm1 isoforms requires cardiolipin and mediates mitochondrial inner membrane fusion","volume":"186","author":"DeVay","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exer.2020.108178_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002341-199609000-00002","article-title":"Extracranial optic canal decompression: indications and technique","volume":"12","author":"Goldberg","year":"1996","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"10.1016\/j.exer.2020.108178_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamaophthalmol.2014.82","article-title":"Traumatic optic neuropathy and second optic nerve injuries","volume":"132","author":"Guy","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2020.108178_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj2890587","article-title":"Tumour necrosis factor-\u03b1 induces superoxide anion generation in mitochondria of L929 cells","volume":"289","author":"Hennet","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.exer.2020.108178_bib14","doi-asserted-by":"crossref","first-page":"17589","DOI":"10.1074\/jbc.M111.330167","article-title":"Cardiolipin and mitochondrial phosphatidylethanolamine have overlapping functions in mitochondrial fusion in Saccharomyces cerevisiae","volume":"287","author":"Joshi","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.exer.2020.108178_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00417-017-3816-5","article-title":"Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial","volume":"256","author":"Kashkouli","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108178_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005805","article-title":"Mitochondrial protective agents for ischemia\/reperfusion injury","volume":"10","author":"Kloner","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.exer.2020.108178_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.001644","article-title":"Reduction of ischemia\/reperfusion injury with bandavia, a mitochondria-targeting cytoprotective peptide","volume":"1","author":"Kloner","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.exer.2020.108178_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0034-1393734","article-title":"Traumatic optic neuropathy: a review","volume":"8","author":"Kumaran","year":"2015","journal-title":"Craniomaxillofacial Trauma Reconstr."},{"issue":"1\u20132","key":"10.1016\/j.exer.2020.108178_bib19","first-page":"53","article-title":"Role of mitochondria in oxidative stress and ageing","volume":"1366","author":"Lenaz","year":"1998","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.exer.2020.108178_bib20","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0161-6420(99)00707-1","article-title":"The treatment of traumatic optic neuropathy: the international optic nerve trauma study","volume":"106","author":"Levin","year":"1999","journal-title":"Ophthalmol. Times"},{"key":"10.1016\/j.exer.2020.108178_bib21","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.eye.6701576","article-title":"Animal models of optic nerve diseases","volume":"18","author":"Levkovitch-Verbin","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.exer.2020.108178_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2010.11.122","article-title":"Mitochondria-targeted antioxidant peptide SS31 attenuates high glucose-induced injury on human retinal endothelial cells","volume":"404","author":"Li","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2020.108178_bib23","first-page":"871","article-title":"Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-\u03baB activation in response to tumor necrosis factor \u03b1","volume":"12","author":"Li","year":"1998","journal-title":"Faseb. J."},{"key":"10.1016\/j.exer.2020.108178_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.redox.2015.08.007","article-title":"SS-31 attenuates TNF-\u03b1 induced cytokine release from C2C12 myotubes","volume":"6","author":"Lightfoot","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.exer.2020.108178_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbabio.2015.03.007","article-title":"Cardiolipin is a key determinant for mtDNA stability and segregation during mitochondrial stress","volume":"1847","author":"Luevano-Martinez","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.exer.2020.108178_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10495-007-0756-2","article-title":"Mitochondria, oxidative stress and cell death","volume":"12","author":"Ott","year":"2007","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.exer.2020.108178_bib27","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000467","article-title":"TNF-alpha and beyond: rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity","volume":"7","author":"Russell","year":"2016","journal-title":"J. Clin. Cell. Immunol."},{"issue":"9","key":"10.1016\/j.exer.2020.108178_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005487","article-title":"Phase 2a clinical trial of mitochondrial protection (elamipretide) during stent revascularization in patients with atherosclerotic renal artery stenosis","volume":"10","author":"Saad","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.exer.2020.108178_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002206","article-title":"Chronic therapy with elamipretide (MTP-131), a novel mitochondria-targeting peptide, improves left ventricular and mitochondrial function in dogs with advanced heart failure","volume":"9","author":"Sabbah","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.exer.2020.108178_bib30","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1016\/S0021-9258(18)42768-8","article-title":"Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions","volume":"267","author":"Schulze-Osthoff","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2020.108178_bib31","first-page":"2","article-title":"Indirect traumatic optic neuropathy","volume":"3","author":"Singman","year":"2016","journal-title":"Mil Med Res"},{"key":"10.1016\/j.exer.2020.108178_bib32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/clpt.2014.174","article-title":"Serendipity and the discovery of novel compounds that restore mitochondrial plasticity","volume":"96","author":"Szeto","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2020.108178_bib33","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2010080808","article-title":"Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury","volume":"22","author":"Szeto","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.exer.2020.108178_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1152\/japplphysiol.00471.2013","article-title":"Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant","volume":"115","author":"Talbert","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.exer.2020.108178_bib35","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1038\/s41598-017-12225-6","article-title":"A novel mouse model of traumatic optic neuropathy using external ultrasound energy to achieve focal, indirect optic nerve injury","volume":"7","author":"Tao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2020.108178_bib36","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1167\/iovs.18-24431","article-title":"Tumor necrosis factor inhibition in the acute management of traumatic optic neuropathy","volume":"59","author":"Tse","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2020.108178_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/abbs\/gmz020","article-title":"Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model","volume":"51","author":"Wu","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.exer.2020.108178_bib39","first-page":"261","article-title":"Incidence of optic canal fracture in the traumatic optic neuropathy and its effect on the visual outcome","volume":"101","author":"Yan","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108178_bib40","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/ars.2009.2445","article-title":"Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity","volume":"11","author":"Yang","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.exer.2020.108178_bib41","doi-asserted-by":"crossref","first-page":"6492858","DOI":"10.1155\/2016\/6492858","article-title":"The outcome of endoscopic transethmosphenoid optic canal decompression for indirect traumatic optic neuropathy with No-Light-Perception","volume":"2016","author":"Yu","year":"2016","journal-title":"J Ophthalmol"},{"issue":"4","key":"10.1016\/j.exer.2020.108178_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005024.pub2","article-title":"Surgery for traumatic optic neuropathy","volume":"19","author":"Yu-Wai-Man","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.exer.2020.108178_bib43","article-title":"Steroids for traumatic optic neuropathy","volume":"19","author":"Yu-Wai-Man","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.exer.2020.108178_bib44","article-title":"Surgery for traumatic optic neuropathy","volume":"18","author":"Yu-Wai-Man","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.exer.2020.108178_bib45","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bcp.2005.08.022","article-title":"Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines","volume":"70","author":"Zhao","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exer.2020.108178_bib46","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2020.108178_bib47","article-title":"SS-31 provides neuroprotection by reversing mitochondrial dysfunction after traumatic brain injury","volume":"4783602","author":"Zhu","year":"2018","journal-title":"Oxid Med Cell Longev"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352030436X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352030436X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:05:01Z","timestamp":1757999101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448352030436X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":46,"alternative-id":["S001448352030436X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108178","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108178"}}